Keppra Solution 100ml

Epilepsy/Convulsion Rx required
M.R.P.: Rs.398.81
TOTAL AMOUNT Rs.398.81
QTY :

What is KEPPRA?

  • KEPPRA contains active ingredients called Levetiracetam which is an antiepileptic medicine 
Therapeutic Uses
Warning & Precautions
Interactions
Directions & For Use
Side Effects
More Information

What KEPPRA is used for?

It is used,

  • to treat a certain form of epilepsy(fits)

Talk to Doctor

Pregnancy & Breast Feeding

Children & Adolescents

Driving & Using Machines

Talk to your doctor before taking KEPPRA, if you

  • are allergic to levetiracetam, pyrrolidone derivatives or any of the other ingredients of this medicine
  • suffer from kidney problems
  • notice any slowdown in the growth or unexpected puberty development of your child
  • have had thoughts of harming or killing themselves
  • have any symptoms of depression and/or suicidal ideation
  • KEPPRA should not be used during pregnancy unless clearly necessary
  • Breast-feeding is not recommended during treatment
  • If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine
  • KEPPRA is not indicated in children and adolescents below 16 years on its own (monotherapy)
  • KEPPRA may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy
  • You should not drive or use machines until it is established that your ability to perform such activities is not affected

Tell your doctor if you are taking or have recently taken or might take any other medicines such as,

  • macrogol (a medicine used for constipation)
  • Always take this medicine exactly as your doctor has told you
  • KEPPRA must be taken twice a day, once in the morning and once in the evening, at about the same time each day

Monotherapy

Dose in adults and adolescents (from 16 years of age)

  • General dose: KEPPRA is taken twice daily, in two equally divided doses, each individual dose being measured between 5 ml (500mg) and 15 ml (1500mg). When you will first start taking KEPPRA, your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose

Dose in adults and adolescents (12 to 17 years)

  • Measure the appropriate dosage using the 10-ml syringe included in the package for patients of 4 years and above
  • General dose: KEPPRA is taken twice daily, in two equally divided doses, each individual dose being measured between 5 ml (500mg) and 15 ml (1500mg)

Dose in children 6 months and older

  • Your doctor will prescribe the most appropriate pharmaceutical form of KEPPRA according to the age, weight and dosee

General dose: KEPPRA is taken twice daily, in two equally divided doses, each individual dose being measured between 0.1 ml (10mg) and 0.3 ml (30mg), per kg bodyweight of the child

If you take more KEPPRA

  • Contact your doctor if you took more KEPPRA than you should. Your doctor will establish the best possible treatment of overdose

If you forget to take KEPPRA

  • Contact your doctor if you have missed one or more doses. Do not take a double dose to make up for a forgotten dose

If you stop taking KEPPRA

  • If stopping treatment, KEPPRA should be discontinued gradually to avoid an increase of seizures. Your doctor should decide to stop your KEPPRA treatment, he/she will instruct you about the gradual withdrawal of KEPPRA
Serious
Common
Uncommon
Rare
Very Rare

Like all medicines, this medicine can cause side effects, although not everybody gets them.

  • weakness, feel light-headed or dizzy or have difficulty breathing, as these may be signs of a serious allergic (anaphylactic) reaction
  • swelling of the face, lips, tongue and throat (Quincke’s oedema)
  • flu-like symptoms and a rash on the face followed by an extended rash with a high temperature
  • low urine volume, tiredness, nausea, vomiting, confusion and swelling in the legs, ankles or feet, as this may be a sign of sudden decrease of kidney function
  • a skin rash which may form blisters and look like small targets (erythema multiforme)
  • a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome)
  • a more severe form of rash causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis)
  • signs of serious mental changes or if someone around you notices signs of confusion, somnolence (sleepiness), amnesia (loss of memory), memory impairment (forgetfulness), abnormal behavior or other neurological signs including involuntary or uncontrolled movements
  • nasopharyngitis
  • somnolence (sleepiness), headache
  • anorexia (loss of appetite)
  • depression, hostility or aggression, anxiety, insomnia, nervousness or irritability
  • convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness), lethargy (lack of energy and enthusiasm), tremor (involuntary trembling)
  • vertigo (sensation of rotation)
  • cough
  • abdominal pain, diarrhea, dyspepsia (indigestion), vomiting, nausea
  • asthenia/fatigue (tiredness)
  • decreased number of blood platelets, decreased number of white blood cells
  • weight decrease, weight increase
  • suicide attempt and suicidal ideation, mental disorder, abnormal behaviour, hallucination, anger, confusion, panic attack, emotional instability/mood swings, agitation
  • amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia (impaired coordinated movements), paraesthesia (tingling), disturbance in attention (loss of concentration); diplopia (double vision), vision blurred elevated/abnormal values in a liver function test
  • hair loss, eczema, pruritus
  • muscle weakness, myalgia (muscle pain)
  • decreased number of all blood cell types
  • decreased blood sodium concentration
  • suicide, personality disorders (behavioral problems), thinking abnormal (slow thinking, unable to concentrate)
  • uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity)
  • pancreatitis
  • liver failure, hepatitis
  • sudden decrease in kidney function
  • rhabdomyolysis (breakdown of muscle tissue) and associated blood creatine phosphokinase increase

NA

Additional Information
Storage

NA

  • Keep this medicine out of reach of children
  • Do not use this medicine after the expiry date
  • Store at room temperature (15-25°C)
  • Do not use after 7 months of first opening the bottle  
Disclaimer:

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

CHECK AVAILABILITY

PINCODE

Copyright© 2019 Netmeds Marketplace Ltd.